Anterior Advantage With KINCISE

Stopped early · Not applicable

Conditions studied: Osteoarthritis, Rheumatoid Arthritis, Post Traumatic Arthritis

In brief

This is a post-market prospective, 1:1 randomized, multicenter non-inferiority study to compare the femoral broaching time for THA with the Anterior Advantage approach with KINCISE vs. without KINCISE. Follow-up will continue through 24 weeks post-op.

Key facts

Study ID: NCT04191733
Run by: DePuy Orthopaedics
People needed: 250
Starts: 2020-01-28
Expected to finish: 2022-08-31
Last updated by the study team: 2023-09-15

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

The patient is undergoing a standard of care primary cementless hip replacement with the Pinnacle cup and a Corail or Actis stem via the Anterior Advantage approach. All devices are to be used according to the approved indications.
Individuals who are able to speak, read, and comprehend the Institutional Review Board approved Informed Consent Document and willing and able to provide informed patient consent for participation in the study and have authorized the transfer of his/her information to DePuy Synthes.
Individuals who are willing and able to complete follow-up visits and questionnaires as specified by the study protocol.
Individuals who are not bedridden per the discretion of the investigator (The intent of "not bedridden" means a permanent situation, not a temporary situation as in a hip fracture or trauma case).
Individuals who are a minimum age of 21 years at the time of consent.

You may not qualify if…

Active local or systemic infection.
Loss of musculature, neuromuscular compromise or vascular deficiency in the affected limb rendering the procedure unjustified.
Poor bone quality, such as osteoporosis, where, in the surgeon's opinion, there could be considerable migration of the prosthesis or a significant chance of fracture of the femoral shaft and/or the lack of adequate bone to support the implant(s).
Charcot's or Paget's disease.
The Subject is a woman who is pregnant or lactating.
Subject had a contralateral amputation.
Previous partial hip replacement in affected hip.
Subject has participated in a clinical investigation with an investigational product (drug or device) in the last three months.
Contralateral hip was replaced less than 3 months prior to surgery date, contralateral hip is already enrolled in the study, or simultaneous or staged hip replacement is planned
Subject is currently involved in any personal injury litigation, medical-legal or worker's compensation claims.
Subject was diagnosed and is taking prescription medications to treat a muscular disorder that limits mobility due to severe stiffness and pain such as fibromyalgia or polymyalgia.
Subject has a medical condition with less than 2 years of life expectancy.
Subject, in the opinion of the Investigator, is a drug or alcohol abuser or has a physical or psychological disorder that could affect their ability to complete patient reported questionnaires or be compliant with follow-up requirements.

Where it is running

The Orthopedic Specialty Center of Northern California — Roseville, California, United States
Colorado Joint Replacement — Denver, Colorado, United States
Capital Region Orthopaedic Group — Albany, New York, United States
Hospital for Special Surgery — New York, New York, United States
Columbia University Medical Center — New York, New York, United States
Carolina Orthopaedic & Sports Medicine — Gastonia, North Carolina, United States
Southern Joint Replacement Institute — Nashville, Tennessee, United States
Texas Institute for Hip and Knee Surgery — Austin, Texas, United States
W.B. Carrell Memorial Clinic — Dallas, Texas, United States
North Texas Medical Research Institute — Dallas, Texas, United States
Jordan-Young Institute — Virginia Beach, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.